# Lumen Technologies, Inc.: financial statements, quarterly

LUMN · Nasdaq · CIK 18926 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lumn.md) · [Financials](/companies/lumn/financials.md) · [Filings](/companies/lumn/filings.md) · [Insiders](/companies/lumn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lumn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,379](/filings/0000018926-24-000111.md) | [3,285 d](/filings/0000018926-26-000014.md) | [3,061](/filings/0000018926-25-000049.md) | [3,018](/filings/0000018926-25-000093.md) | [2,967](/filings/0000018926-25-000111.md) | [3,083 d](/filings/0000018926-26-000014.md) | [2,911](/filings/0000018926-26-000046.md) | [2,869](/filings/0000018926-26-000060.md) | [2,806](/filings/0000018926-25-000111.md) | [2,745 d](/filings/0000018926-26-000014.md) | [2,598](/filings/0000018926-26-000046.md) | [2,507](/filings/0000018926-26-000060.md) |
| Cost of revenue | $m | [1,850](/filings/0000018926-24-000111.md) | [1,737 d](/filings/0000018926-26-000014.md) | [1,652](/filings/0000018926-25-000049.md) | [1,653](/filings/0000018926-25-000093.md) | [1,692](/filings/0000018926-25-000111.md) | [1,706 d](/filings/0000018926-26-000014.md) | [1,687](/filings/0000018926-26-000046.md) | [1,624](/filings/0000018926-26-000060.md) | [1,700](/filings/0000018926-25-000111.md) | [1,627 d](/filings/0000018926-26-000014.md) | [1,435](/filings/0000018926-26-000046.md) | [1,415](/filings/0000018926-26-000060.md) |
| Selling, general and administrative | $m | [791](/filings/0000018926-24-000111.md) | [896 d](/filings/0000018926-26-000014.md) | [823](/filings/0000018926-25-000049.md) | [742](/filings/0000018926-25-000093.md) | [696](/filings/0000018926-25-000111.md) | [711 d](/filings/0000018926-26-000014.md) | [675](/filings/0000018926-26-000046.md) | [755](/filings/0000018926-26-000060.md) | [829](/filings/0000018926-25-000111.md) | [940 d](/filings/0000018926-26-000014.md) | [794](/filings/0000018926-26-000046.md) | [779](/filings/0000018926-26-000060.md) |
| Operating income | $m | [223](/filings/0000018926-24-000111.md) | [(1,776) d](/filings/0000018926-26-000014.md) | [45.0](/filings/0000018926-25-000049.md) | [135](/filings/0000018926-25-000093.md) | [126](/filings/0000018926-25-000111.md) | [154 d](/filings/0000018926-26-000014.md) | [107](/filings/0000018926-26-000046.md) | [(603)](/filings/0000018926-26-000060.md) | [(116)](/filings/0000018926-25-000111.md) | [(200) d](/filings/0000018926-26-000014.md) | [602](/filings/0000018926-26-000046.md) | [(88.0)](/filings/0000018926-26-000060.md) |
| Interest expense | $m | [295](/filings/0000018926-23-000100.md) | [290 d](/filings/0000018926-26-000014.md) | [291](/filings/0000018926-24-000054.md) | [373](/filings/0000018926-25-000093.md) | [351](/filings/0000018926-25-000111.md) | [357 d](/filings/0000018926-26-000014.md) | [347](/filings/0000018926-26-000046.md) | [338](/filings/0000018926-26-000060.md) | [319](/filings/0000018926-25-000111.md) | [280 d](/filings/0000018926-26-000014.md) | [225](/filings/0000018926-26-000046.md) | [201](/filings/0000018926-26-000060.md) |
| Income tax | $m | [(7.0)](/filings/0000018926-24-000111.md) | [(147) d](/filings/0000018926-26-000014.md) | [45.0](/filings/0000018926-25-000049.md) | [8.0](/filings/0000018926-25-000093.md) | [(24.0)](/filings/0000018926-25-000111.md) | [(204) d](/filings/0000018926-26-000014.md) | [(44.0)](/filings/0000018926-26-000046.md) | [(234)](/filings/0000018926-26-000060.md) | [(192)](/filings/0000018926-25-000111.md) | [(507) d](/filings/0000018926-26-000014.md) | [377](/filings/0000018926-26-000046.md) | [(54.0)](/filings/0000018926-26-000060.md) |
| Net income | $m | [(78.0)](/filings/0000018926-24-000111.md) | [(1,995) d](/filings/0000018926-26-000014.md) | [57.0](/filings/0000018926-25-000049.md) | [(49.0)](/filings/0000018926-25-000093.md) | [(148)](/filings/0000018926-25-000111.md) | [85.0 d](/filings/0000018926-26-000014.md) | [(201)](/filings/0000018926-26-000046.md) | [(915)](/filings/0000018926-26-000060.md) | [(621)](/filings/0000018926-25-000111.md) | [(2.0) d](/filings/0000018926-26-000014.md) | [(200)](/filings/0000018926-26-000046.md) | [(201)](/filings/0000018926-26-000060.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0000018926-24-000111.md) | not reported | [0.06](/filings/0000018926-25-000049.md) | [(0.05)](/filings/0000018926-25-000093.md) | [(0.15)](/filings/0000018926-25-000111.md) | not reported | [(0.20)](/filings/0000018926-26-000046.md) | [(0.92)](/filings/0000018926-26-000060.md) | [(0.62)](/filings/0000018926-25-000111.md) | not reported | [(0.20)](/filings/0000018926-26-000046.md) | [(0.20)](/filings/0000018926-26-000060.md) |
| Basic EPS | $ per share | [(0.08)](/filings/0000018926-24-000111.md) | not reported | [0.06](/filings/0000018926-25-000049.md) | [(0.05)](/filings/0000018926-25-000093.md) | [(0.15)](/filings/0000018926-25-000111.md) | not reported | [(0.20)](/filings/0000018926-26-000046.md) | [(0.92)](/filings/0000018926-26-000060.md) | [(0.62)](/filings/0000018926-25-000111.md) | not reported | [(0.20)](/filings/0000018926-26-000046.md) | [(0.20)](/filings/0000018926-26-000060.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0000018926-24-000111.md) | [2.2](/filings/0000018926-26-000014.md) | [1.6](/filings/0000018926-25-000049.md) | [1.5](/filings/0000018926-25-000093.md) | [2.6](/filings/0000018926-25-000111.md) | [1.9](/filings/0000018926-26-000014.md) | [1.9](/filings/0000018926-26-000046.md) | [1.6](/filings/0000018926-26-000060.md) | [2.4](/filings/0000018926-25-000111.md) | [1.0](/filings/0000018926-26-000060.md) | [1.6](/filings/0000018926-26-000046.md) | [1.9](/filings/0000018926-26-000060.md) |
| Current assets | $bn | [4.6](/filings/0000018926-23-000100.md) | [4.8](/filings/0000018926-25-000010.md) | [3.9](/filings/0000018926-24-000054.md) | [3.8](/filings/0000018926-24-000094.md) | [4.7](/filings/0000018926-24-000111.md) | [4.4](/filings/0000018926-26-000014.md) | [4.3](/filings/0000018926-25-000049.md) | [7.7](/filings/0000018926-25-000093.md) | [8.7](/filings/0000018926-25-000111.md) | [7.9](/filings/0000018926-26-000060.md) | [4.1](/filings/0000018926-26-000046.md) | [4.1](/filings/0000018926-26-000060.md) |
| Total assets | $bn | [35.9](/filings/0000018926-23-000100.md) | [34.0](/filings/0000018926-25-000010.md) | [33.2](/filings/0000018926-24-000054.md) | [32.9](/filings/0000018926-24-000094.md) | [34.0](/filings/0000018926-24-000111.md) | [33.5](/filings/0000018926-26-000014.md) | [33.5](/filings/0000018926-25-000049.md) | [33.0](/filings/0000018926-25-000093.md) | [34.3](/filings/0000018926-25-000111.md) | [34.3](/filings/0000018926-26-000060.md) | [30.6](/filings/0000018926-26-000046.md) | [30.8](/filings/0000018926-26-000060.md) |
| Current liabilities | $bn | [3.9](/filings/0000018926-23-000100.md) | [3.5](/filings/0000018926-25-000010.md) | [3.8](/filings/0000018926-24-000054.md) | [3.7](/filings/0000018926-24-000094.md) | [3.9](/filings/0000018926-24-000111.md) | [3.6](/filings/0000018926-26-000014.md) | [3.5](/filings/0000018926-25-000049.md) | [3.6](/filings/0000018926-25-000093.md) | [3.9](/filings/0000018926-25-000111.md) | [4.4](/filings/0000018926-26-000060.md) | [4.2](/filings/0000018926-26-000046.md) | [4.3](/filings/0000018926-26-000060.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.2](/filings/0000018926-24-000111.md) | [0.4](/filings/0000018926-26-000014.md) | [0.5](/filings/0000018926-25-000049.md) | [0.5](/filings/0000018926-25-000093.md) | [0.3](/filings/0000018926-25-000111.md) | [0.5](/filings/0000018926-26-000014.md) | [0.3](/filings/0000018926-26-000046.md) | [(0.6)](/filings/0000018926-26-000060.md) | [(1.2)](/filings/0000018926-25-000111.md) | [(1.1)](/filings/0000018926-26-000060.md) | [(1.3)](/filings/0000018926-26-000046.md) | [(1.5)](/filings/0000018926-26-000060.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [881 d](/filings/0000018926-24-000111.md) | [784 d](/filings/0000018926-26-000014.md) | [1,102](/filings/0000018926-25-000049.md) | [511 d](/filings/0000018926-25-000093.md) | [2,032 d](/filings/0000018926-25-000111.md) | [688 d](/filings/0000018926-26-000014.md) | [1,095](/filings/0000018926-26-000046.md) | [570 d](/filings/0000018926-26-000060.md) | [2,511 d](/filings/0000018926-25-000111.md) | [562 d](/filings/0000018926-26-000014.md) | [1,323](/filings/0000018926-26-000046.md) | [971 d](/filings/0000018926-26-000060.md) |
| Capital expenditure | $m | [843 d](/filings/0000018926-24-000111.md) | [821 d](/filings/0000018926-26-000014.md) | [713](/filings/0000018926-25-000049.md) | [753 d](/filings/0000018926-25-000093.md) | [850 d](/filings/0000018926-25-000111.md) | [915 d](/filings/0000018926-26-000014.md) | [791](/filings/0000018926-26-000046.md) | [891 d](/filings/0000018926-26-000060.md) | [1,041 d](/filings/0000018926-25-000111.md) | [1,644 d](/filings/0000018926-26-000014.md) | [943](/filings/0000018926-26-000046.md) | [902 d](/filings/0000018926-26-000060.md) |
| Dividends paid | $m | [1.0 d](/filings/0000018926-24-000111.md) | [1.0 d](/filings/0000018926-26-000014.md) | [3.0](/filings/0000018926-25-000049.md) | [0.0 d](/filings/0000018926-24-000094.md) | [0.0 d](/filings/0000018926-24-000111.md) | [0.0 d](/filings/0000018926-26-000014.md) | [1.0](/filings/0000018926-25-000049.md) | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,017](/filings/0000018926-23-000100.md) | [982](/filings/0000018926-24-000054.md) | [983](/filings/0000018926-24-000094.md) | [984](/filings/0000018926-24-000111.md) | [986](/filings/0000018926-25-000049.md) | [987](/filings/0000018926-25-000093.md) | [989](/filings/0000018926-25-000111.md) | [991](/filings/0000018926-26-000046.md) | [995](/filings/0000018926-26-000060.md) | [996](/filings/0000018926-25-000111.md) | [999](/filings/0000018926-26-000046.md) | [1,004](/filings/0000018926-26-000060.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,031,445,404 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000018926-26-000060.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.